3 . 20 . 2026Press releaseGalderma publishes invitation and agenda for its 2026 Annual General Meeting
The Board of Directors proposes a dividend of 0.35 CHF per registered shareHarry Kirsch proposed as...
Publisher
Switzerland
This page provides a limited summary and publisher metadata to support discovery before sending readers to the original article.
Read originalIn-platform summary, original article off-platform
This page presents the title, publisher metadata, and a limited summary excerpt to help users judge relevance first. Full-text reading stays on the publisher's original site.
Summary excerpt
The Board of Directors proposes a dividend of 0.35 CHF per registered shareHarry Kirsch proposed as...
Source route
Continue on galderma.com
Leave the platform to read the original full article on the publisher site.
Source: Galderma
Scope: Industry
Related coverage
More related coverage
Mar.26.2026R & DOno Pharma Submits an Application for Approval of Ripretinib (DCC-2618) in Patients with Advanced Gastrointestinal Stromal Tumor in Japan
Application submitted for manufacturing and marketing approval of ripretinib in Japan for the indica...
March 25, 2026
Terns’ lead candidate TERN-701 is an investigational oral allosteric BCR::ABL1 tyrosine kinase inhib...